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Abstract
We report a case of a 67-year-old Caucasian man with right upper quadrant abdominal pain. He
underwent radiologic investigations that revealed a solid, focal mass, at the V hepatic segment.
Because a definitive diagnosis, based on imaging appearance of the lesion, was impossible in our
case, we performed a hystopathological investigation but the biopsies were inconclusive. So, the
definitive diagnosis of intraductal papillary mucinous tumor of bile ducts was made on surgical
resected material.
Intraductal papillary neoplasm of the liver (IPNL) is a recently recognized entity which closely
resembles an intraductal papillary mucinous tumor (IPMT) of the pancreas.
Background
Papillary tumors of the intrahepatic bile ducts are charac-
terized by intraluminal growth, sometimes in papillary
masses with bile duct obstruction and dilatation. Papil-
lary tumors generally produce a large amount of mucin
and so they may occasionally impede the flow of the bile
juice and cause a severe ductal dilatation. Intraductal pap-
illary neoplasm of the liver (IPNL) is a recently recognized
entity frequently reported in association with hepatolithi-
asis and resembling intraductal papillary mucinous tumor
(IPMT) of the pancreas, in terms of its histopathology,
pathophysiology, and excessive mucin production [1-5].
Case report
A 67-year-old Caucasian man underwent an ultrasound
investigation because he suffered from right upper quad-
rant subcontinuous abdominal pain. The ultrasound
examination and the successive Computed Tomography
(CT)-examination, this last performed using an Aquilion
64 slice (Toshiba Medical System, Zoetmeer, Nether-
lands) revealed a solid, focal mass, about 3 cm in diame-
ter, at the V hepatic segment in the presence of diffuse
steatosis. On CT the mass presented hypodense respect to
the surrounding tissue during the basal phase (Figure 1)
and with a light peripherical enhanced rim in the arterial
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phase that increased in the portal venous phase. (Figure 2,
3) In late phase, the lesion showed a puntacte aspect
because of the presence of intralesional hypervascular
spots. (Figure 4) The bile ducts did not appear dilatated.
The patient was admitted to the medical department of
our hospital for further investigation. On admission,
physical examination and laboratory findings were nor-
mal (included negative hepatitis B and C – biomarkers),
showing only a mild increase of alpha-feto-protein (73
IU/mL).
Transverse CT scanFigure 1
Transverse CT scan. It reveals a solid focal mass, about 3 
cm in diameter, hypodense respect to the surrounding tissue 
in the basal phase (1) with a light peripherical enhanced rim 
in the arterial phase (2) that increases in the portal venous 
phase (3). In late phase (4), the lesion shows a puntacte 
aspect because of the presence of intralesional hypervascular 
spots (arrow). The bile ducts are not dilatated.
Transverse CT scanFigure 2
Transverse CT scan. It reveals a solid focal mass, about 3 
cm in diameter, hypodense respect to the surrounding tissue 
in the basal phase (1) with a light peripherical enhanced rim 
in the arterial phase (2) that increases in the portal venous 
phase (3). In late phase (4), the lesion shows a puntacte 
aspect because of the presence of intralesional hypervascular 
spots (arrow). The bile ducts are not dilatated.
Transverse CT scanFigure 3
Transverse CT scan. It reveals a solid focal mass, about 3 
cm in diameter, hypodense respect to the surrounding tissue 
in the basal phase (1) with a light peripherical enhanced rim 
in the arterial phase (2) that increases in the portal venous 
phase (3). In late phase (4), the lesion shows a puntacte 
aspect because of the presence of intralesional hypervascular 
spots (arrow). The bile ducts are not dilatated.
Transverse CT scanFigure 4
Transverse CT scan. It reveals a solid focal mass, about 3 
cm in diameter, hypodense respect to the surrounding tissue 
in the basal phase (1) with a light peripherical enhanced rim 
in the arterial phase (2) that increases in the portal venous 
phase (3). In late phase (4), the lesion shows a puntacte 
aspect because of the presence of intralesional hypervascular 
spots (arrow). The bile ducts are not dilatated.
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At this time, the patient underwent a upper abdominal
Magnetic Resonance (MR) investigation, performed with
a Eclipse 1.5 T (Picker-Marconi, Philips, Eindhoven, Neth-
erlands) which showed the mass hypointense in T1 W
unenhanced images and slightly dishomogeneous hyper-
intense in sequences with long TR. (Figure 5) After admin-
istration of paramagnetic contrast agent, the lesion
presented the same dynamic behaviour as on CT includ-
ing the appearance of intralesional hypervascular spots in
late phase. (Figure 6)
The lesion suggested different diagnostic hypotheses,
from a peripherical cholangiocarcinoma to a primitive
degenerated mass characterized by an unusual dynamic
pattern or a dysplastic nodule with focal hepatocellular
carcinoma and this last diagnostic hypothesis was con-
firmed by contrast enhanced ultrasound (CEUS).
Two different biopsies were performed using Biomol 21 G
(H.S. Medical, USA), one revealed inconclusive and the
other showed only the presence of a micronodular cirrho-
sis that was regarded associated to non-alcoholic steato-
hepatitis.
Finally, the patient was admitted to the surgical depart-
ment of our hospital for the treatment.
The mass was therefore excised by segmentectomy of the
V hepatic segment, and after that the patient had an une-
ventful postoperative course.
The liver lesion was 3 cm in the larger size; growing within
a bile duct as a well demarcated large mass, no dilatation,
stone or mucin were found in the large intrahepatic bile
ducts around the lesion. Samples of the lesion were for-
malin fixed, paraffin embedded and stained with hema-
Transverse RM scanFigure 5
Transverse RM scan. It reveals a slightly dishomogeneous hyperintense mass in sequences with long TR (5) and the appear-
ance of intralesional hypervascular spots (arrow) in late phase after administration of paramagnetic contrast agent (6).
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toxylin and eosin (H&E) and Alcian Blue and periodic
acid Schiff stain (AB-PAS).
Immunostaining for MUC1, MUC2, MUC5AC, MUC6,
CDX2, CK-7, and CK-20 were performed on sections spec-
imens that were dewaxed and rehydrated using Bio-clear
(Bio-Optica, Milan, Italy) and graded alcohols. Endog-
enous peroxidase was blocked dipping sections in 3%
aqueous hydrogen peroxide for 10' and antigen retrieval
was performed with 10' microwave treatment in 10 mM
citrate buffer, pH 6.00. The immunostaining was per-
formed with the avidin-biotin-peroxidase complex tech-
nique using diaminobenzidine as chromogen. The
sections were incubated overnight at 4°C with mono-
clonal antibodies against CDX2-88 (Biogenex) raised
against a full-length CDX2 recombinant protein at 1:100
dilution, CK7 (clone OV-TL 12/30; Dako Cytomation at
1:50 dilution) and CK20 (cloneKs.20.8; Dako Cytoma-
tion at 1:50 dilution). The apomucines were studied by
using a mouse monoclonal antibodies against MUC-1
glycoprotein (MA695, Novacastra Lab., Newcastle, UK) at
1:100 dilution; MUC-2 glycoprotein (CCP58, Novacastra
Lab., Newcastle, UK) at 1:200 dilution; MUC-5AC glyco-
protein (CLH2, Novacastra Lab., Newcastle, UK) at 1:100
dilutionand MUC-6 glycoprotein (CLH5, Novacastra
Lab., Newcastle, UK) at 1:100 dilution. The neoplasm was
made of papillary proliferation with thin fibrovascular
stalk, covered by mild to moderate dysplastic epithelium,
with tall columnar cells, mainly of mucinous type. A lim-
ited area of the tumor, showing an oncocitic pattern, was
made of cuboidal cell with acidophilic, granular cyto-
plasm and prominent nucleoli. No goblet cells were
found. (Figure 7, 8, 9, 10, 11, 12)
The immunohistochemical test showed a diffuse CK7+/
CK20- pattern of neoplastic cells. The apomucines
Transverse RM scanFigure 6
Transverse RM scan. It reveals a slightly dishomogeneous hyperintense mass in sequences with long TR (5) and the appear-
ance of intralesional hypervascular spots (arrow) in late phase after administration of paramagnetic contrast agent (6).
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MUC5AC and MUC6 were positive in more than 50% of
neoplastic cells, indicating a gastric foveolar phenotype
while CDX2 and MUC2 were negative, indicating that
intestinal phenotype was completely absent; also MUC1
was negative. On the basis of these findings a diagnosis of
borderline (gastric type) was made.
The successive CT follow up examinations showed the
patient free of the disease. (Figure 13)
Discussion
Intraductal papillary mucinous tumor of the bile ducts is
characterized by innumerable frondlike infoldings of pro-
liferated columnar epithelial cells and slender fibrovascu-
lar stalks that are supported by connective tissue from the
lamina propria [1,2]. At histopathologic analysis it may
present as adenocarcinoma, adenoma, dyspalsia or as a
mixed form [1].
Papillary cholangiocarcinoma rappresents 3–5% of the
reported cholangiocarcinomas [6].
Papillary adenocarcinoma is a low-grade malignancy that
grows slowly and tends to spread along the mucosal sur-
face and invading the ductal wall in the late phase of the
development [1,2,7].
Pathological sections specimensFigure 7
Pathological sections specimens. (7) Low magnification 
showing encapsulated papillary tumor with thin fibrovascular 
stalk, covered by tall mucinous moderately dysplastic epithe-
lium (8). Higher magnification demonstrates area with oncoc-
itic pattern (9). The immunohistochemical test showed a 
diffuse CK7+ (10) and apomucines MUC5AC (11) and MUC6 
(12) positivity in more than 50% of neoplastic cells.
Pathological sections specimensFigure 8
Pathological sections specimens. (7) Low magnification 
showing encapsulated papillary tumor with thin fibrovascular 
stalk, covered by tall mucinous moderately dysplastic epithe-
lium (8). Higher magnification demonstrates area with oncoc-
itic pattern (9). The immunohistochemical test showed a 
diffuse CK7+ (10) and apomucines MUC5AC (11) and MUC6 
(12) positivity in more than 50% of neoplastic cells.
Pathological sections specimensFigure 9
Pathological sections specimens. (7) Low magnification 
showing encapsulated papillary tumor with thin fibrovascular 
stalk, covered by tall mucinous moderately dysplastic epithe-
lium (8). Higher magnification demonstrates area with oncoc-
itic pattern (9). The immunohistochemical test showed a 
diffuse CK7+ (10) and apomucines MUC5AC (11) and MUC6 
(12) positivity in more than 50% of neoplastic cells.
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Papillomatosis represents a known condition where
tumors are multiple and extend along bile ducts [1,2].
Intraductal papillary tumor produces a variable amount
of mucin that may be retained in the lesion. Some tumors
produce a large amount of mucin that is discharged into
Pathological sections specimensFigure 10
Pathological sections specimens. (7) Low magnification 
showing encapsulated papillary tumor with thin fibrovascular 
stalk, covered by tall mucinous moderately dysplastic epithe-
lium (8). Higher magnification demonstrates area with oncoc-
itic pattern (9). The immunohistochemical test showed a 
diffuse CK7+ (10) and apomucines MUC5AC (11) and MUC6 
(12) positivity in more than 50% of neoplastic cells.
Pathological sections specimensFigure 11
Pathological sections specimens. (7) Low magnification 
showing encapsulated papillary tumor with thin fibrovascular 
stalk, covered by tall mucinous moderately dysplastic epithe-
lium (8). Higher magnification demonstrates area with oncoc-
itic pattern (9). The immunohistochemical test showed a 
diffuse CK7+ (10) and apomucines MUC5AC (11) and MUC6 
(12) positivity in more than 50% of neoplastic cells.
Pathological sections specimensFigure 12
Pathological sections specimens. (7) Low magnification 
showing encapsulated papillary tumor with thin fibrovascular 
stalk, covered by tall mucinous moderately dysplastic epithe-
lium (8). Higher magnification demonstrates area with oncoc-
itic pattern (9). The immunohistochemical test showed a 
diffuse CK7+ (10) and apomucines MUC5AC (11) and MUC6 
(12) positivity in more than 50% of neoplastic cells.
CT follow up examinationFigure 13
CT follow up examination. It shows the patient free of 
the disease.
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the bile ducts and may intermittently and partially
impede the flow of bile juice, causing obstructive jaun-
dice, sometimes complicated by cholangitis or stone for-
mation. Endoscopy may show mucin draining from the
papilla of Vater. This condition is diagnostic of a mucin-
producing tumor of the bile or pancreatic ducts. When the
mucin flow obstructs the duodenal papilla, both proximal
and distal to the tumor bile ducts become diffusely
dilated. So dilatation can be caused by the presence of the
lesion as by the mucin excretion. Dilatation may affect
only the segmental or lobar bile ducts or the entire biliary
tree depending on the location of the cause. Moreover, the
dilatation in bile ducts containing tumor may be dispro-
portionate with that in the surrounding biliary tree [1,2].
The clinical manifestations are consisting in upper
abdominal pain, episodic biliary pain, fever and jaundice.
These symptoms are related to the recurrent obstruction
of the bile ducts [1].
The imaging techniques used for the study of papillary
bile ducts neoplasms include ultrasonography (US), CT,
endoscopic retrograde cholangiopancreatography (ERCP)
and MR cholangiopancreatography that reveal bile ducts
dilatation with or without visible intraductal papillary
lesion [1,2,8].
Bile ducts that contain a mucinous intraductal papillary
tumor may dilate diffusely or focally like an aneurysm and
this presentation, such as the disproportionate lobar dila-
tation of the bile ducts where the tumor is localized than
the ducts in the controlateral lobe, are considered a char-
acteristic sign of the presence of an intraductal papillary
mucinous tumor. So the involved bile ducts may dilate
aneurysmlike, whereas others diffusely and proportion-
ally [1,2].
Despite the study of Lim et al., where imaging techniques
showed the presence of bile duct dilatation in all 15
patients, our case was not associated to bile duct dilata-
tion, probably because the tumor was localized peripher-
ically.
At US papillary tumor can appear as an echogenic mass.
The echogenicity is similar to that of the liver and there is
no acoustic shadow. In our case, the lesion appeared hyp-
oechogenic in the presence of surrounding steatosis. On
CT the neoplasm presents as intraluminal soft-tissue mass
enhancing or nonenhancing depending on whether the
tumor is connected to the wall or not. When it is fixed, it
shows confined within the ducts and preserves the bile
ducts wall integrity. Moreover, the tumor can present as
asymmetric enhanced thickening of the bile duct wall
[2,8]. Besides, the tumor may not be depicted when it is
small and isoattenuating to the adjacent hepatic tissue or
when the complex orientation of the dilated ducts
obscures the mass [2].
Yoon et al, describing the CT findings in 15 patients
affected by malignant papillary neoplasms of intrahepatic
bile ducts, reported that most of the tumors were hypo- or
isoattenuating on contrast-enhanced CT. Conversely, CT
could reveal an intraductal hypoattenuating mass associ-
ated with markedly dilated intra- and extrahepatic bile
ducts in the three patients with mucin-hypersecreting pap-
illary cholangiocarcinoma [6].
In this case, the appearance of a mass showing hypovascu-
lar with the enhanced rim in later phases, suggesting the
presence of a capsule, could invite to include the hepato-
cellular carcinoma with atypical features in the differential
diagnosis. Early stages like a dysplastic nodule with focal
degenerated areas was a inconsistent hypothesis because
the focal hypervascular degenerated areas did not show in
the arterial phase. The low attenuation of the lesion in the
arterial and venous portal sequences and the elongated
morphology, as in our case, could suggest the presence of
a peripheral cholangiocarcinoma but, on the contrary, the
late intralesional enhancement was poor [9]. Because a
definitive diagnosis, based on imaging appearance of the
lesion, was impossible in our case, we decided to perform
a hystopathological investigation but the biopsies were
inconclusive. So, the definitive diagnosis was made on
surgical resected material.
The use of ERCP is recommended to detect the presence
and the location of the suspected neoplasm and to reveal
the presence and the quantity of mucin draining from
duodenal papilla. Moreover, ERCP permits biopsy perfor-
mation [1]. This last procedure could not be performed in
our case because the tumor was peripherical.
On ERCP the lesion appears as filling defect representing
papillary tumor or as fine irregularities of the bile duct
wall with a velvety or serrated contour.
On US mucin is echo-free but may appear as a echogenic
focus; on CT it is water-attenuating.
Instead, ERCP may show small or large, elongated or
amorphous filling defects caused by mucin presence in
the dilated ducts.
Various conditions present as filling defects in the dilated
ducts and include air bubbles, stones, blood clots, and
intraluminal tumors [2,10,11].
However, the papillary tumors of the bile ducts are char-
acterized by the inconsistency and changeability of the
imaging findings. Moreover, there can be differences
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between the radiologic and surgical presentation, and
both these can differ from the pathologic findings but
when intraductal masses are seen with localized dilatation
of the intrahepatic bile ducts, papillary tumor of the bile
ducts should be included in the differential diagnosis.
Otherwise, the diagnosis may be made on the basis of his-
topathologic examination, as in our case [6,8].
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